News

Harrow Unveils Exciting Details for Upcoming Investor Day

Harrow Unveils Exciting Details for Upcoming Investor Day

Harrow Announces Investor & Analyst Day Details

Harrow, a prominent provider of ophthalmic disease management solutions in North America, has officially revealed the agenda for its highly anticipated Investor & Analyst Day. This event is scheduled for Friday, September 26, and will run from 11:30 a.m. to 3 p.m. ET. Attendees can join in-person in New York or access the live webcast.

Comprehensive Overview of Harrow

The Investor & Analyst Day promises a thorough overview of Harrow's business, featuring presentations from its leadership team. These sessions will shed light on Harrow's commercial portfolio, development pipeline, and long-term vision for the company. Notably, esteemed physician key opinion leaders will present insights on the evolving treatment paradigms and market dynamics affecting patient care.

Key Speakers to Feature

The lineup of featured speakers includes:

  • Paul Karpecki, OD: A respected optometrist specializing in cornea and external disease. His extensive experience in dry eye disease will provide valuable insight.
  • Raj Patel, MD, MS: A retinal specialist with expertise in macular degeneration and diabetic retinopathy, whose research and innovative treatment approaches are highly regarded.
  • Seenu Hariprasad, MD: An internationally recognized vitreoretinal surgeon known for developing impactful surgical techniques and conducting significant clinical research.
  • Maggie Jeffries, MD, FASA: Specializing in ophthalmic anesthesia and renowned for her contributions to outpatient surgical techniques.

Investor Day Agenda

The preliminary agenda of the Investor & Analyst Day includes a number of enlightening topics:

  • Welcome & Opening Remarks by Mike Biega, VP of IR and Communications.
  • Harrow Overview & Vision by Mark L. Baum, Chief Executive Officer.
  • Financial Update presented by Andrew Boll, President & Chief Financial Officer.
  • Harrow's Pipeline Products overview by Amir Shojaei, Chief Scientific Officer.
  • MELT-300 Development Overview and Potential by Larry Dillaha, MD, CEO of Melt Pharmaceuticals.
  • An Expert's Perspective on Procedural Sedation by Maggie Jeffries, MD.
  • Commercial Vision by Patrick Sullivan, Head of Commercial.
  • VEVYE Overview led by Maria Lloyd, VP of Dry Eye.
  • Patient Access & Affordability of Specialty Products by Prashanth Annavajjhala, Chief of Staff to CEO.
  • Retina Products Overview presented by Aly Harrison, VP of Retina Portfolio.

Register to Attend

In-person attendance is specifically open to invited research analysts and institutional investors only. For those interested in attending in-person, please reach out to Mike Biega via email. The live video webcast is open to all others wishing to join the event virtually.

Webcast Information

The live webcast will be accessible on the Harrow website, while a replay will also be available shortly after the event concludes. A copy of the slide presentation will be shared on this webpage at the event's start.

About Harrow

Harrow, Inc. (NASDAQ: HROW) is a leading provider of ophthalmic disease management solutions throughout North America. The company focuses on delivering a comprehensive range of products aimed at treating conditions affecting both the front and back of the eye, which include prevalent issues like dry eye disease, wet age-related macular degeneration, and cataracts. Harrow's core mission is to ensure medications are safe, effective, and affordable, ultimately enhancing patient compliance and outcomes.

Frequently Asked Questions

What is the purpose of Harrow's Investor & Analyst Day?

The event aims to provide an in-depth overview of Harrow's business strategies, product pipeline, and future vision to investors and analysts.

Who are the main speakers at the event?

Notable speakers include Dr. Paul Karpecki, Dr. Raj Patel, Dr. Seenu Hariprasad, and Dr. Maggie Jeffries, among others.

How can I register for the event?

Investors and analysts may register to attend in person by contacting Mike Biega directly via email. The webcast will be accessible to the general public.

What topics will be covered during the presentations?

The agenda includes topics about Harrow's vision, financial updates, and insights from leading experts in ophthalmology regarding current treatment paradigms.

Where can I access the live webcast?

The live webcast will be available on Harrow's official website, along with a replay after the event.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 31

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 68

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
1031 Specialists Takes Tax Deferral to Public TV

Updated Category News Views 100

A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 5

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 44

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 70

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Sivers Moves Q3 Release to Accommodate U.S. Investors

Updated Category News Views 74

Thanksgiving has a nasty habit of turning perfectly ordinary earnings dates into ghost towns, and Sivers Semiconductors has sensibly stepped around that pothole. The company will publish its third-quarter 2026 interim report on Monday, November 30, rather than Thursday, November 26. That is not a strategy reset, a warning, or some grand corporate mystery. It is a calendar...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 103

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 75

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading

Top 5 Most Recently Viewed Articles

Long-Term Efficacy of FINTEPLA in Managing Lennox-Gastaut Syndrome

Updated Category News Views 124

Long-Term Efficacy of FINTEPLA in Managing Lennox-Gastaut Syndrome FINTEPLA, known scientifically as fenfluramine, has demonstrated remarkable potential in treating seizures associated with Lennox-Gastaut syndrome (LGS) as confirmed by a significant open-label extension (OLE) study. This study emphasized the drug's beneficial effects, particularly in lowering seizure...

Continue Reading
Implications of U.S. Withdrawal from the Paris Agreement

Updated Category News Views 370

Significance of the U.S. Withdrawal from the Paris Agreement The decision by the U.S. to withdraw from the Paris Agreement is a critical moment not just for America, but for the entire globe. Analysts and climate diplomats suggest that this move will have far-reaching consequences, more profound than those witnessed during the initial exit in recent years. Accelerating...

Continue Reading
Ambarella's Oculii AI Technology Enhances Lotus Electric Vehicles

Updated Category News Views 236

Ambarella's Oculii AI Radar Transforms Lotus Vehicles In a major technological breakthrough, Ambarella has announced the worldwide rollout of its Oculii™ AI 4D imaging radar technology in Lotus's 2023 and 2024 electric vehicles. This advanced technology is integrated into the eye-catching Lotus Eletre electric hyper-SUV and the thrilling Lotus Emeya hyper-GT models....

Continue Reading
Luxury Brands Adapt to Broader Market with Affordable Options

Updated Category News Views 355

Luxury Brands Embrace Affordability for Wider Appeal In recent times, luxury brands have found themselves in a challenging position. With diminishing demand for high-priced items like $3,000 handbags and $4,000 cashmere jackets, many luxury labels are shifting their focus. They are creating a wider array of products targeting the middle-class customer, including...

Continue Reading
Elife Group's Game-Changing Platform for Global Transport Solutions

Updated Category News Views 328

Elife Group Launches Revolutionary Multi-Modal Travel Platform Elife Group has introduced an innovative multi-modal platform that redefines ground transportation. By seamlessly integrating rail and ride-hailing services into a single platform, they have created a comprehensive solution for travelers seeking convenient and efficient options. This strategic move positions...

Continue Reading